Zimmer Biomet Holdings Inc

Describe the process(es) your organization has in place to ensure that your engagement activities are consistent with your overall climate change strategy[…]Zimmer Biomet published near term Science Based Targets in 2020 and formally committed to reduce absolute scope 1 and 2 GHG emissions 55% by 2030 from a 2017 base year. Zimmer Biomet also commits to reduce absolute scope 3 GHG emissions from purchased goods and services 15% by 2030 from a 2019 base year. Zimmer Biomet's near term Science Based Targets are aligned with a 1.5 degree C scenario by 2030. Zimmer Biomet manages the multiple engagement activities around climate change across business divisions and geographies to ensure that we have a common approach that is also consistent with our strategy on climate change. We integrate environmental health and safety principles into business decisions to proactively ensure the health and safety of our employees and communities, while also promoting environmentally sustainable practices. Specifically, we require that an EHSS evaluation be integrated into product design, manufacturing and distribution business processes and services that will reduce EHSS risks, improve performance throughout our operations, products and packaging across their lifecycle, and promote pollution prevention. Zimmer Biomet is committed to participating constructively and responsibly in the public policy process. Government policy proposals to regulate the healthcare system may
directly affect Zimmer Biomet's business and the incentives for innovation. There are also important policy proposals that can further our business interests, including those of our shareholders. Zimmer Biomet actively seeks to inform the debate on these proposals in the United States and in other countries. We also support policies that advance the interests of patients, improve public health and promote access to healthcare and innovation. The primary means by which we engage in public policy debate is through communication of information to government officials, policy makers and their staffs.

Does your organization have a public commitment or position statement to conduct your engagement activities in line with the goals of the Paris Agreement?[…]Yes

Describe the process(es) your organization has in place to ensure that your external engagement activities are consistent with your climate commitments and/or climate transition plan?[…]Zimmer Biomet published near term Science Based Targets in 2020 and formally committed to reduce absolute scope 1 and 2 GHG emissions 55% by 2030 from a 2017 base year. Zimmer Biomet also commits to reduce absolute scope 3 GHG emissions from purchased goods and services 15% by 2030 from a 2019 base year. Zimmer Biomet's near term Science Based Targets are aligned with a 1.5 degree C scenario by 2030. Zimmer Biomet manages the multiple engagement activities around climate change across business divisions and geographies to ensure that we have a common approach that is also consistent with our strategy on climate change. We integrate environmental health and safety principles into business decisions to proactively ensure the health and safety of our employees and communities, while also promoting environmentally sustainable practices. Specifically, we require that an EHSS evaluation be integrated into product design, manufacturing and distribution business processes and services that will reduce EHSS risks, improve performance throughout our operations, products and packaging across their lifecycle, and promote pollution prevention. Zimmer Biomet is committed to participating constructively and responsibly in the public policy process. Government policy proposals to regulate the healthcare system may directly affect Zimmer Biomet's business and the incentives for innovation. There are also important policy proposals that can further our business interests, including those of our shareholders. Zimmer Biomet actively seeks to inform the debate on these proposals in the United States and in other countries. We also support policies that advance the interests of patients, improve public health and promote access to healthcare and innovation. The primary means by which we engage in public policy debate is through communication of information to government officials, policy makers and their staffs.